10A NCAC 41A .0102. METHOD OF REPORTING  


Latest version.
  • (a)  When a report of a disease or condition is required to be made pursuant to G.S. 130A‑135 through 139 and 10A NCAC 41A .0101, with the exception of laboratories, which shall proceed as in Subparagraph (d), the report shall be made to the local health director as follows:

    (1)           For diseases and conditions required to be reported within 24 hours, the initial report shall be made by telephone, and the report required by Subparagraph (2) of this Paragraph shall be made within seven days.

    (2)           In addition to the requirements of Subparagraph (1) of this Paragraph, the report shall be made on the communicable disease report card or in an electronic format provided by the Division of Public Health and shall include the name and address of the patient, the name and address of the parent or guardian if the patient is a minor, and epidemiologic information.

    (3)           In addition to the requirements of Subparagraphs (1) and (2) of this Paragraph, forms or electronic formats provided by the Division of Public Health for collection of information necessary for disease control and documentation of clinical and epidemiologic information about the cases shall be completed and submitted for the following reportable diseases and conditions identified in 10A NCAC 41A .0101(a):

    (A)          acquired immune deficiency syndrome (AIDS);

    (B)          brucellosis;

    (C)          cholera;

    (D)          cryptosporidiosis;

    (E)           cyclosporiasis;

    (F)           E. coli 0157:H7 infection;

    (G)          ehrlichiosis;

    (H)          Haemophilus influenzae, invasive disease;

    (I)            Hemolytic-uremic syndrome/thrombotic thrombocytopenic purpura;

    (J)            hepatitis A;

    (K)          hepatitis B;

    (L)           hepatitis B carriage;

    (M)         hepatitis C;

    (N)          human immunodeficiency virus (HIV) confirmed;

    (O)          legionellosis;

    (P)           leptospirosis;

    (Q)          Lyme disease;

    (R)          malaria;

    (S)           measles (rubeola);

    (T)           meningitis, pneumococcal;

    (U)          meningococcal disease;

    (V)          mumps;

    (W)         paralytic poliomyelitis;

    (X)          psittacosis;

    (Y)          Rocky Mountain spotted fever;

    (Z)           rubella;

    (AA)       rubella congenital syndrome;

    (BB)       tetanus;

    (CC)       toxic shock syndrome;

    (DD)       trichinosis;

    (EE)        tuberculosis;

    (FF)         tularemia;

    (GG)       typhoid;

    (HH)       typhoid carriage (Salmonella typhi);

    (II)          vibrio infection (other than cholera); and

    (JJ)          whooping cough.

    Communicable disease report cards, surveillance forms, and electronic formats are available from the Division of Public Health, 1915 Mail Service Center, Raleigh, North Carolina 27699-1915, and from local health departments.

    (b)  Notwithstanding the time frames established in 10A NCAC 41A .0101, a restaurant or other food or drink establishment shall report all outbreaks or suspected outbreaks of foodborne illness in its customers or employees and all suspected cases of foodborne disease or foodborne condition in food‑handlers at the establishment by telephone to the local health department within 24 hours in accordance with Subparagraph (a)(1) of this Rule.  However, the establishment is not required to submit a report card or surveillance form pursuant to Subparagraph (a)(2) of this Rule.

    (c)  For the purposes of reporting by restaurants and other food or drink establishments pursuant to G.S.130A‑138, the following diseases and conditions listed in 10A NCAC 41A .0101(a) shall be reported:

    (1)           anthrax;

    (2)           botulism;

    (3)           brucellosis;

    (4)           campylobacter infection;

    (5)           cholera;

    (6)           cryptosporidiosis;

    (7)           cyclosporiasis;

    (8)           E. coli 0157:H7 infection;

    (9)           hepatitis A;

    (10)         salmonellosis;

    (11)         shigellosis;

    (12)         streptococcal infection, Group A, invasive disease;

    (13)         trichinosis;

    (14)         tularemia;

    (15)         typhoid;

    (16)         typhoid carriage (Salmonella typhi); and

    (17)         vibrio infection (other than cholera). 

    (d)  Laboratories required to report test results pursuant to G.S. 130A‑139 and 10A NCAC 41A .0101(c) shall report as follows:

    (1)           The results of the specified tests for syphilis, chlamydia and gonorrhea shall be reported to the local health department by the first and fifteenth of each month.  Reports of the results of the specified tests for gonorrhea, chlamydia and syphilis shall include the specimen collection date, the patient's age, race, and sex, and the submitting physician's name, address, and telephone numbers.

    (2)           Positive darkfield examinations for syphilis, all reactive prenatal and delivery STS titers, all reactive STS titers on infants less than one year old and STS titers of 1:8 and above shall be reported within 24 hours by telephone to the HIV/STD Prevention and Care Branch at (919) 733‑7301, or the HIV/STD Prevention and Care Branch Regional Office where the laboratory is located.

    (3)           With the exception of positive laboratory tests for human immunodeficiency virus, positive laboratory tests as defined in G.S. 130A-139(1) and 10A NCAC 41A .0101(c) shall be reported to the Division of Public Health electronically, by mail, by secure telefax or by telephone within the time periods specified for each reportable disease or condition in 10A NCAC 41A .0101(a). Confirmed positive laboratory tests for human immunodeficiency virus as defined in 10A NCAC 41A .0101(b) and for CD4 results defined in 10A NCAC 41A .0101(c)(4) shall be reported to the HIV/STD Prevention and Care Branch within 24 hours of obtaining reportable test results.  Reports shall include as much of the following information as the laboratory possesses:

    (A)          the specific name of the test performed;

    (B)          the source of the specimen;

    (C)          the collection date(s);

    (D)          the patient's name, age, race, sex, address, and county; and

    (E)           the submitting physician's name, address, and telephone number.

     

History Note:        Authority G.S. 130A‑134; 130A‑135; 130A‑138; 130A‑139; 130A‑141;

Temporary Rule Eff. February 1, 1988, for a period of 180 days to expire on July 29, 1988;

Eff. March 1, 1988;

Amended Eff. October 1, 1994; February 3, 1992; December 1, 1991; May 1, 1991;

Temporary Amendment Eff. December 16, 1994, for a period of 180 days or until the permanent rule becomes effective, whichever is sooner;

Temporary Amendment Expired June 16, 1995;

Amended Eff. December 1, 2007; November 1, 2007; August 1, 2005, April 1, 2003; August 1, 1998.